182 related articles for article (PubMed ID: 38135061)
1. Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.
Dehner CA; Rudzinski ER; Davis JL
Hum Pathol; 2024 May; 147():72-81. PubMed ID: 38135061
[TBL] [Abstract][Full Text] [Related]
2. Evolving classification of rhabdomyosarcoma.
Agaram NP
Histopathology; 2022 Jan; 80(1):98-108. PubMed ID: 34958505
[TBL] [Abstract][Full Text] [Related]
3. The current landscape of rhabdomyosarcomas: an update.
Leiner J; Le Loarer F
Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361
[TBL] [Abstract][Full Text] [Related]
4. [Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues].
Mentzel T
Pathologe; 2010 Mar; 31(2):91-6. PubMed ID: 19997735
[TBL] [Abstract][Full Text] [Related]
5. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
Parham DM; Giannikopoulos P
Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
[TBL] [Abstract][Full Text] [Related]
6. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
[TBL] [Abstract][Full Text] [Related]
7. Update on Myogenic Sarcomas.
Agaram NP
Surg Pathol Clin; 2019 Mar; 12(1):51-62. PubMed ID: 30709448
[TBL] [Abstract][Full Text] [Related]
8. An Integrative Morphologic and Molecular Approach for Diagnosis and Subclassification of Rhabdomyosarcoma.
Fan R; Parham DM; Wang LL
Arch Pathol Lab Med; 2022 Aug; 146(8):953-959. PubMed ID: 35051261
[TBL] [Abstract][Full Text] [Related]
9. Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma.
Dehner CA; Geiersbach K; Rowsey R; Murugan P; Broski SM; Meis JM; Rosenberg AE; Folpe AL
Mod Pathol; 2023 Jun; 36(6):100131. PubMed ID: 36966552
[TBL] [Abstract][Full Text] [Related]
10. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
Folpe AL; McKenney JK; Bridge JA; Weiss SW
Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: report of two cases.
Chrisinger JSA; Wehrli B; Dickson BC; Fasih S; Hirbe AC; Shultz DB; Zadeh G; Gupta AA; Demicco EG
Virchows Arch; 2020 Nov; 477(5):725-732. PubMed ID: 32556562
[TBL] [Abstract][Full Text] [Related]
12. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526
[TBL] [Abstract][Full Text] [Related]
13. Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma-diagnostic challenge and report of two cases.
Carrillo-Ng H; Liang Y; Chang S; Afkhami M; Gernon T; Bell D; Arias-Stella JA
Genes Chromosomes Cancer; 2023 Jul; 62(7):430-436. PubMed ID: 37057803
[TBL] [Abstract][Full Text] [Related]
14. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.
Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR
Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123
[TBL] [Abstract][Full Text] [Related]
15. The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Rudzinski ER; Anderson JR; Hawkins DS; Skapek SX; Parham DM; Teot LA
Arch Pathol Lab Med; 2015 Oct; 139(10):1281-7. PubMed ID: 25989287
[TBL] [Abstract][Full Text] [Related]
16. Intergroup Rhabdomyosarcoma Study: update for pathologists.
Qualman SJ; Coffin CM; Newton WA; Hojo H; Triche TJ; Parham DM; Crist WM
Pediatr Dev Pathol; 1998; 1(6):550-61. PubMed ID: 9724344
[TBL] [Abstract][Full Text] [Related]
17. Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases.
Mentzel T; Kuhnen C
Virchows Arch; 2006 Nov; 449(5):554-60. PubMed ID: 17013628
[TBL] [Abstract][Full Text] [Related]
18. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
[TBL] [Abstract][Full Text] [Related]
19. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies.
Parham DM
Mod Pathol; 2001 May; 14(5):506-14. PubMed ID: 11353062
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]